Oct 27, 2015 | Class Action Lawsuit, Defective Drugs, Diabetes, Drug Side Effects, Mass Tort, Pharmaceutical Litigation
FDA Increases Invokana Warning On September 10th, the U.S. Food and Drug Administration (FDA) released an increased warning as it pertains to the diabetes drug Invokana (canagliflozin). This dangerous drug is used to treat Type 2 Diabetes, but in reality poses an...
